Why aren't we figuring out how to cure the test bottleneck?
The parent of BioReference Labs is sending some bullish signals amid a nice recent run higher in its shares.
The bulls are clearly in control.
In this market, winning stocks 'stick out like a sore thumb.'
UNH is trading like investors are anticipating a positive earnings report.
Our analysis and trading strategy on this 'wild bunch' stock.
Experts pick their favorite long-term investments in medical diagnostics, testing and laboratory services.
WBA could rally some from here.
PTON is in an uptrend with no signs of selling.
TheStreet's quantitative service gives a buy recommendation for Align Technologies and it looks like a dip could be an opportunity for investors.